Sequencing for Families with Hereditary Disorders

Overview

About this study

The purpose of this project will examine the feasibility of offering whole genome sequencing (WGS), and developing a Rapid WGS protocol, for a fetus or neonate with multiple anomalies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Affected infant and both parents (trios).  However,  duos (infant and one parent) may be considered in certain extenuating circumstances where one parent is unavailable (for example, parental death).
  • Consenting parents will be >18 at the time of consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Myra Wick, M.D., Ph.D.

Open for enrollment

Contact information:

Center for Individualized Medicine

(507)293-0792

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20307537

Mayo Clinic Footer